Foekens JA - Search Results

1

Prognostic significance of TP53 accumulation in human primary breast cancer: comparison between a rapid quantitative immunoassay and SSCP analysis.

de Witte HH, Foekens JA, Lennerstrand J, Smid M, Look MP, Klijn JG, Benraad TJ, Berns EM. de Witte HH, et al. Among authors: foekens ja. Int J Cancer. 1996 Apr 22;69(2):125-30. doi: 10.1002/(SICI)1097-0215(19960422)69:2<125::AID-IJC10>3.0.CO;2-8. Int J Cancer. 1996. PMID: 8608980 Free article.

2

The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancer.

Foekens JA, Ries C, Look MP, Gippner-Steppert C, Klijn JG, Jochum M. Foekens JA, et al. Cancer Res. 2003 Jan 15;63(2):337-41. Cancer Res. 2003. PMID: 12543785

3

Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer.

Berns EM, Klijn JG, Look MP, Grebenchtchikov N, Vossen R, Peters H, Geurts-Moespot A, Portengen H, van Staveren IL, Meijer-van Gelder ME, Bakker B, Sweep FC, Foekens JA. Berns EM, et al. Among authors: foekens ja. Clin Cancer Res. 2003 Apr;9(4):1253-8. Clin Cancer Res. 2003. PMID: 12684392

4

Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.

Berns EM, Klijn JG, Henzen-Logmans SC, Rodenburg CJ, van der Burg ME, Foekens JA. Berns EM, et al. Among authors: foekens ja. Int J Cancer. 1992 Sep 9;52(2):218-24. doi: 10.1002/ijc.2910520211. Int J Cancer. 1992. PMID: 1325950 Free article.

5

Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients.

Foekens JA, Schmitt M, van Putten WL, Peters HA, Bontenbal M, Jänicke F, Klijn JG. Foekens JA, et al. Cancer Res. 1992 Nov 1;52(21):6101-5. Cancer Res. 1992. PMID: 1394237

6

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.

Berns EM, Klijn JG, van Putten WL, van Staveren IL, Portengen H, Foekens JA. Berns EM, et al. Among authors: foekens ja. Cancer Res. 1992 Mar 1;52(5):1107-13. Cancer Res. 1992. PMID: 1737370

7

Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer.

Foekens JA, Portengen H, Janssen M, Klijn JG. Foekens JA, et al. Cancer. 1989 Jun 1;63(11):2139-47. doi: 10.1002/1097-0142(19890601)63:11<2139::aid-cncr2820631112>3.0.co;2-d. Cancer. 1989. PMID: 2541884

8

Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.

Foekens JA, Portengen H, van Putten WL, Peters HA, Krijnen HL, Alexieva-Figusch J, Klijn JG. Foekens JA, et al. Cancer Res. 1989 Nov 1;49(21):5823-8. Cancer Res. 1989. PMID: 2676151

9

Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer.

Berns EM, Klijn JG, Smid M, van Staveren IL, Gruis NA, Foekens JA. Berns EM, et al. Among authors: foekens ja. Br J Cancer. 1995 Oct;72(4):964-7. doi: 10.1038/bjc.1995.442. Br J Cancer. 1995. PMID: 7547249 Free PMC article.

10

Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer.

Foekens JA, Look MP, Peters HA, van Putten WL, Portengen H, Klijn JG. Foekens JA, et al. J Natl Cancer Inst. 1995 May 17;87(10):751-6. doi: 10.1093/jnci/87.10.751. J Natl Cancer Inst. 1995. PMID: 7563153

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters